Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1995-3-9
|
| pubmed:abstractText |
Reports of thrush clinically refractory to azoles in AIDS patients are increasing with the more widespread use of these agents. We studied our own oral preparation of amphotericin B in the treatment of two AIDS patients who developed oral thrush due to Candida glabrata after prolonged fluconazole use. Improvement occurred in both in less than 1 week, with eventual clearing and absence of side effects. Oral amphotericin B may have advantages over alternatives for this increasing problem.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0268-1218
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
389-93
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7844704-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:7844704-Administration, Oral,
pubmed-meshheading:7844704-Adult,
pubmed-meshheading:7844704-Amphotericin B,
pubmed-meshheading:7844704-Candidiasis, Oral,
pubmed-meshheading:7844704-Cost-Benefit Analysis,
pubmed-meshheading:7844704-Drug Resistance, Microbial,
pubmed-meshheading:7844704-Fluconazole,
pubmed-meshheading:7844704-Humans,
pubmed-meshheading:7844704-Male,
pubmed-meshheading:7844704-Treatment Outcome
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
|
| pubmed:affiliation |
Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128-2699.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|